Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02110394
Eligibility Criteria:
Inclusion Criteria:
* Patients with chronic lymphocytic leukemia (CLL) with current or planned first line therapy with Ribomustin
* Informed Consent Form for personal data handling signed by the program participant
Exclusion Criteria:
* Any prior chemotherapy and/or radiotherapy and/or immunotherapy and/or any investigational agent for treatment of CLL
* Currently participating in any clinical trial, and/or has taken an investigational drug within 28 days prior to enrollment
* Contraindications for Ribomustin usage in accordance with product label
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02110394
Study Brief:
Protocol Section:
NCT02110394